A great proportion of patients (126/240, 52.5%, Supplementary Table S1) with high risk of tumor recurrence received prophylactic therapy after resection, which would reasonably obscure the prognostic influence of intratumoral GATA2. This evidence concerns the gene GATA2 and neoplasm.